AlphaCentric Advisors’s Progyny PGNY Stock Holding History

AlphaCentric Advisors’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-7,500	Closed	-$126K	–	267
2024 Q3	$126K	Buy	+7,500	New	+$180K	0.09%	164

Other funds holding PGNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AlphaCentric Advisors's PGNY Position: Q4 2024 in Review

AlphaCentric Advisors sold out of Progyny (PGNY) in Q4 2024, closing a stake of 7,500 shares — an estimated $126K sold.

AlphaCentric Advisors first reported a position in PGNY in Q3 2024 and held it in 1 quarter. The position peaked at $126K in Q3 2024. 264 funds tracked by Wall St. Rank hold PGNY as of Q4 2024.

AlphaCentric Advisors reported no remaining Progyny position as of Q4 2024 after selling out during the quarter.
AlphaCentric Advisors sold 7,500 Progyny shares in Q4 2024, an estimated $126K.
AlphaCentric Advisors first reported a position in Progyny in Q3 2024 and held it in 1 quarter.
AlphaCentric Advisors's Progyny position peaked at $126K in Q3 2024.
264 funds tracked by Wall St. Rank held Progyny as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.